Yüklüyor......
Anti-CD33 chimeric antigen receptor targeting of acute myeloid leukemia
Current therapies for acute myeloid leukemia are associated with high failure and relapse rates. Adoptive immunotherapies, which have shown promise in the treatment of hematologic malignancies, have the potential to target acute myeloid leukemia through pathways that are distinct and complementary t...
Kaydedildi:
| Yayımlandı: | Haematologica |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Ferrata Storti Foundation
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4349272/ https://ncbi.nlm.nih.gov/pubmed/25480499 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2014.112748 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|